Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital

Stephen J. Wilson, Cynthia J. Knipe, Madeline J. Zieger, Kari M. Gabehart, Joyce E. Goodman, Helen M. Volk, Rajiv Sood

Research output: Contribution to journalArticle

65 Scopus citations

Abstract

We conducted a case-control study to determine the attributable direct costs of multidrug-resistant Acinetobacter baumannii (MDRAB) in the burn unit of a public teaching hospital. The mean total hospital cost of patients who acquired MDRAB was $98,575 higher than that of control patients who had identical burn severity of illness indices (P <. 01). These data should help infection control practitioners and others determine the cost-effectiveness of specific interventions designed to control this emerging nosocomial pathogen.

Original languageEnglish (US)
Pages (from-to)342-344
Number of pages3
JournalAmerican Journal of Infection Control
Volume32
Issue number6
DOIs
StatePublished - Oct 1 2004

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital'. Together they form a unique fingerprint.

  • Cite this